Medtech Matters

153 Episoder

1. Benefit-Risk Determinations

   Publisert: 16.9.2019
2. Mike on Medtech: Beyond 510(k)/PMA—Breakthrough Devices Program

   Publisert: 6.8.2019
3. Beyond 510(k)/PMA—De Novo 101

   Publisert: 2.7.2019
4. Mike on Medtech: The NYT Editorial Board Statement

   Publisert: 17.6.2019
5. The Alternative Summary Reporting Program

   Publisert: 24.5.2019
6. Do we need a pre-sub for 483s? (Part 2)

   Publisert: 9.5.2019
7. Do we need a pre-sub for 483s?

   Publisert: 9.5.2019
8. FDA's Material Evaluation

   Publisert: 2.4.2019
9. 510k Modernization

   Publisert: 25.1.2019
10. Personalized Healthcare

    Publisert: 3.1.2019
11. My Holiday Wish List (Part 2)

    Publisert: 11.12.2018
12. My Holiday Wish List (Part 1)

    Publisert: 4.12.2018
13. Regulating the Practice of Medicine

    Publisert: 26.10.2018
14. The Bleeding Edge, Part 3

    Publisert: 26.9.2018
15. The Bleeding Edge, Part 2

    Publisert: 7.9.2018
16. The Bleeding Edge, Part 1

    Publisert: 5.9.2018
17. Breakthrough Designation Program

    Publisert: 10.8.2018
18. 15 Tips for Getting New Products Through FDA

    Publisert: 3.7.2018
19. Voice-Enabled Medtech

    Publisert: 17.5.2018
20. Changing Pathway to Market?

    Publisert: 25.4.2018